Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms.

Science Translational Medicine
Alessandro PrestipinoRobert Zeiser

Abstract

Recent evidence has revealed that oncogenic mutations may confer immune escape. A better understanding of how an oncogenic mutation affects immunosuppressive programmed death ligand 1 (PD-L1) expression may help in developing new therapeutic strategies. We show that oncogenic JAK2 (Janus kinase 2) activity caused STAT3 (signal transducer and activator of transcription 3) and STAT5 phosphorylation, which enhanced PD-L1 promoter activity and PD-L1 protein expression in JAK2V617F-mutant cells, whereas blockade of JAK2 reduced PD-L1 expression in myeloid JAK2V617F-mutant cells. PD-L1 expression was higher on primary cells isolated from patients with JAK2V617F-myeloproliferative neoplasms (MPNs) compared to healthy individuals and declined upon JAK2 inhibition. JAK2V617F mutational burden, pSTAT3, and PD-L1 expression were highest in primary MPN patient-derived monocytes, megakaryocytes, and platelets. PD-1 (programmed death receptor 1) inhibition prolonged survival in human MPN xenograft and primary murine MPN models. This effect was dependent on T cells. Mechanistically, PD-L1 surface expression in JAK2V617F-mutant cells affected metabolism and cell cycle progression of T cells. In summary, we report that in MPN, constitutive JAK2...Continue Reading

References

Sep 20, 2000·The Journal of Experimental Medicine·B SidoS C Meuer
Feb 27, 2001·Nature Immunology·Y LatchmanG J Freeman
Dec 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michal MarzecMariusz A Wasik
Jan 27, 2011·European Journal of Immunology·Sabine J WölfleKlaus Heeg
Nov 28, 2013·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Suzanne M KoopmansArienne M W van Marion
Jul 21, 2014·Nature Genetics·Sarah E FlanaganAndrew T Hattersley
Nov 15, 2014·Cell Death and Differentiation·T M SchnöderT Fischer
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Aug 12, 2015·The Journal of Experimental Medicine·Michael D BuckErika L Pearce
Mar 5, 2016·Leukemia Research·Jen Chin WangHemant Sindhu
Mar 12, 2016·Science·Stephanie C CaseyDean W Felsher
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaretha G M RoemerMargaret A Shipp
Jun 10, 2016·Nature·Keisuke KataokaSeishi Ogawa
Jul 15, 2016·The New England Journal of Medicine·Matthew S DavidsUNKNOWN Leukemia and Lymphoma Society Blood Cancer Research Partnership
May 13, 2017·Cell Reports·Angel Garcia-DiazAntoni Ribas
Aug 17, 2017·Nature·Riccardo MezzadraTon N M Schumacher

❮ Previous
Next ❯

Citations

Aug 23, 2018·Virchows Archiv : an International Journal of Pathology·Thomas Menter, Alexandar Tzankov
Jul 16, 2019·The Journal of Clinical Investigation·Li-Chuan ChanMien-Chie Hung
May 21, 2020·Blood·Andrew J DunbarRoss Levine
Aug 29, 2020·Annals of Hematology·Andrea MarraStefano Ascani
Sep 18, 2020·Cellular and Molecular Life Sciences : CMLS·Yuan WeiDong-Ming Kuang
Jul 11, 2018·Seminars in Immunopathology·Morten Orebo Holmström, Hans Carl Hasselbalch
Oct 17, 2018·Expert Review of Hematology·Eran ZimranMarina Kremyanskaya
Sep 6, 2019·Journal of Oncology·Paolo Bernasconi, Oscar Borsani
Mar 2, 2019·Nature Reviews. Immunology·David O'SullivanErika L Pearce
Jan 28, 2020·The Journal of Clinical Investigation·Livius Penter, Catherine J Wu
Aug 14, 2020·Journal of Hematology & Oncology·Basit SalikKyohei Nakamura
Aug 31, 2018·Current Hematologic Malignancy Reports·Roberta ZappasodiTaha Merghoub
Feb 8, 2019·Science Translational Medicine·Alessandro Prestipino, Robert Zeiser
Dec 7, 2019·Hematology·Nils B Leimkühler, Rebekka K Schneider
Apr 5, 2020·Nature Communications·Shaima'a HamarshehRobert Zeiser
Jun 13, 2019·International Journal of Molecular Sciences·Barbora BrodskáKateřina Kuželová
Sep 1, 2019·International Journal of Molecular Sciences·Peter ValentDominik Wolf
Sep 18, 2020·Science Translational Medicine·Pavan BachireddyCatherine J Wu
Jun 23, 2019·Current Hematologic Malignancy Reports·Lucia MasarovaSrdan Verstovsek
Jul 2, 2020·Cells·Lukas M Braun, Robert Zeiser
Oct 18, 2018·Frontiers in Immunology·Uffe KlausenMads Hald Andersen
Oct 21, 2020·Expert Review of Hematology·Jan Philipp Bewersdorf, Amer M Zeidan
Nov 15, 2018·Cancer Research·Justin MastroianniRobert Zeiser
Jan 4, 2021·International Journal of Hematology·Ryujiro HaraKiyoshi Ando
Oct 31, 2020·International Journal of Molecular Sciences·Ji-Yoon NohHaiyoung Jung
Dec 4, 2020·Journal of Hematology & Oncology·Sangeetha Venugopal, John Mascarenhas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.